mucos
infect
caus
emerg
pathogen
bacteria
virus
mucos
transmit
replic
mucos
tissu
pathogen
enter
human
singl
multipl
mucos
site
oral
nasal
conjunctiv
respiratori
gastrointestin
genitourinari
tract
invad
bloodstream
final
lead
infect
approxim
death
children
younger
year
due
mucos
infect
bacteria
streptococcu
pneumonia
staphylococcu
aureu
anaerob
bacteria
streptococcu
viridan
enterobacteriacea
virus
haemophilu
influenza
corona
viru
human
adenoviru
caus
mucos
infect
mucos
infect
treat
antibiot
vaccin
administ
oral
parenter
nasal
rout
nasal
vaccin
induc
mucos
immun
respons
system
immun
provid
better
protect
infecti
agent
yet
develop
vaccin
deliveri
system
induc
humor
cellmedi
respons
mucos
immun
challeng
date
differ
mucos
rout
explor
use
differ
deliveri
system
nasal
rout
prefer
compar
mucos
rout
mucos
rout
vaccin
deliveri
one
better
altern
convent
multipl
inject
vaccin
employ
traumat
procedur
may
also
lead
spread
infecti
agent
via
contamin
syring
mucos
vaccin
develop
grown
extens
multitud
vaccin
deliveri
system
develop
applic
via
ocular
nasal
oral
rectal
vagin
rout
differ
rout
mucos
vaccin
oral
nasal
rout
accept
easili
access
mani
decad
intranas
applic
tobacco
snuff
cocain
variou
hallucinogen
psychotrop
agent
practic
similarli
mani
year
synthet
drug
administ
intranas
local
effect
mucosa
eg
antihistamin
antibiot
nonpeptid
drug
first
nasal
influenza
vaccin
introduc
later
withdrawn
market
due
potenti
toxic
problem
anoth
intranas
vaccin
flumist
launch
administ
use
syring
sprayer
success
vaccin
depend
deliveri
also
rout
administr
exampl
nasal
immun
elicit
potent
immunoglobulin
iga
secret
respiratori
tract
nasal
administr
vaccin
shown
achiev
better
system
bioavail
protect
gastric
enzym
compar
parenter
oral
administr
nasal
deliveri
vaccin
act
first
entri
block
block
pathogen
entri
invad
mucos
surfac
induc
local
microbialspecif
immun
respons
thu
increas
gener
efficaci
vaccin
addit
vaccin
uptak
blood
circulatori
system
absorpt
mucosa
rel
fast
appropri
method
immun
rich
cell
b
cell
plasma
cell
stimul
antigenspecif
system
mucos
adapt
immun
respons
provid
better
patient
complianc
due
needlefre
deliveri
nasal
rout
consid
attract
rout
vaccin
administr
follow
advantag
better
patient
complianc
numer
microvilli
present
nasal
epithelium
provid
better
absorpt
surfac
mucos
system
immun
respons
induc
easi
immun
larg
popul
group
nasal
immun
requir
needl
syring
mani
challeng
stand
way
develop
nasal
vaccin
nasal
vaccin
administ
directli
mucos
surfac
antigen
may
dilut
mucos
secret
seiz
mucu
gel
attack
proteas
nucleas
obstruct
epitheli
barrier
major
challeng
develop
nasal
vaccin
includ
rel
larg
dose
vaccin
requir
difficult
administ
nasal
rout
also
difficult
monitor
actual
dose
cross
mucosa
costli
innov
vaccin
strategi
efficaci
nasal
vaccin
may
limit
due
includ
mucociliari
clearanc
ineffici
uptak
solubl
antigen
nasal
epitheli
cell
nasal
caviti
nasal
deliveri
may
requir
adjuv
enhanc
immunogen
deliveri
mucos
tissu
lack
multipl
humancompat
mucos
adjuv
rapid
nasal
clearanc
may
allow
suffici
retent
antigen
taken
antigenpres
cell
apc
nasalassoci
lymphoid
tissu
nalt
sever
enzym
present
nasal
mucosa
might
affect
stabil
drug
exampl
protein
peptid
subject
degrad
proteas
aminopeptidas
mucos
membran
deliveri
volum
nasal
caviti
restrict
high
molecular
weight
compound
deliv
rout
mass
cutoff
kda
low
antigen
entrap
effici
mode
normal
defens
mechan
like
mucociliari
clearanc
ciliari
beat
affect
permeabl
drug
nose
vital
organ
human
bodi
breath
nose
complex
role
complet
system
defens
inhal
air
air
condit
nasal
anatom
physiolog
structur
provid
support
nasal
immun
upper
respiratori
mucos
diseas
nasal
anatomi
nasal
morpholog
physiolog
nasal
secret
nasal
mucosa
olfactori
region
blood
suppli
nasal
caviti
describ
respect
link
vaccin
administr
rout
nasal
caviti
protect
viscerocranium
human
head
human
nose
divid
median
septum
two
symmetr
halv
half
open
face
nostril
extend
posteriorli
nasopharynx
nasal
caviti
nasal
vestibul
anterior
part
open
face
nostril
atrium
place
intermedi
region
vestibul
respiratori
region
respiratori
region
nasal
turbin
occupi
area
nasal
caviti
possess
later
wall
divid
three
section
compos
superior
nasal
turbin
superior
region
nasal
turbin
middl
region
inferior
turbin
inferior
region
attach
turbin
later
wall
complex
anim
human
fold
provid
nasal
caviti
high
surfac
area
compar
small
volum
basic
function
nose
filtrat
particl
heat
humidif
inspir
air
reach
lung
olfactori
region
situat
superior
nasal
turbin
possess
special
ciliat
olfactori
nerv
cell
smell
percept
human
nasal
caviti
total
volum
ml
total
surfac
area
approxim
cm
respiratori
region
cover
nasal
caviti
subdivid
differ
region
nasal
vestibul
turbin
inferior
middl
superior
olfactori
region
frontal
sinu
sphenoid
sinu
cribriform
plate
ethmoid
bone
nalt
present
nasal
caviti
situat
nasopharynx
central
axon
nerv
cell
pass
cribriform
plate
ethmoid
bone
olfactori
bulb
nasal
vestibul
numer
nasal
hair
vibrissa
filter
larg
airborn
particl
fig
anterior
section
nasal
portion
constitut
stratifi
squamou
epithelium
sebac
gland
posterior
section
nasal
portion
pseudostratifi
columnar
cell
present
microvilli
nasal
respiratori
mucosa
consid
import
area
deliv
drug
system
made
epithelium
basement
membran
lamina
propria
nasal
respiratori
epithelium
consist
pseudostratifi
columnar
epitheli
cell
goblet
cell
basal
cell
mucou
serou
gland
epitheli
cell
apic
surfac
microvilli
major
part
fine
project
call
cilia
nasal
secret
nasal
mucosa
olfactori
region
blood
suppli
nasal
caviti
play
major
role
nasal
physiolog
nasal
secret
origin
mostli
submucos
gland
goblet
cell
mucu
compos
water
glycoprotein
albumin
immunogobulin
lysozym
lactoferrin
protein
inorgan
salt
lipid
glycoprotein
low
proport
provid
mucu
characterist
viscoelast
properti
mucu
layer
divid
low
viscos
lower
layer
thick
viscou
upper
layer
thick
human
nasal
ph
approxim
averag
baselin
nasal
respiratori
mucosa
consist
epithelium
basement
membran
lamina
propria
nasal
respiratori
epithelium
contain
pseudostratifi
columnar
epitheli
cell
goblet
cell
basal
cell
mucou
serou
gland
mani
epitheli
cell
cover
apic
surfac
fine
project
microvilli
call
cilia
enhanc
respiratori
surfac
area
nasal
epithelium
cover
thin
mucu
layer
produc
secretori
gland
goblet
cell
nasal
mucu
respons
sever
physiolog
function
humidif
warm
inhal
air
offer
physic
enzymat
protect
olfactori
region
locat
top
nasal
caviti
cm
extend
septum
later
wall
neuroepithelium
part
central
nervou
system
cn
directli
expos
extern
environ
olfactori
area
made
pseudostratifi
columnar
epithelium
compos
support
cell
basal
cell
microvillar
cell
typic
receptor
olfactori
cell
olfactori
region
also
contain
olfactori
receptor
receptor
smell
sensat
small
serou
gland
produc
secret
act
solvent
total
surfac
area
olfactori
epithelium
mm
nasal
caviti
vasculatur
requir
rich
blood
suppli
fulfil
basic
physiolog
function
heat
humidif
olfact
mucociliari
clearanc
immunolog
role
nasal
vascular
bed
intend
rapid
easi
exchang
fluid
dissolv
excipi
blood
vessel
nasal
tissu
capillari
flow
nasal
mucosa
report
mlgmin
antigen
uptak
nose
mostli
two
mechan
paracellular
aqueou
pathway
transcellular
lipoid
process
fig
effici
area
drug
absorpt
highli
vascular
later
wall
nasal
caviti
mucosa
line
turbin
concha
paracellular
mechan
antigen
uptak
nasal
aqueou
rout
transport
rout
slow
passiv
process
mainli
depend
invers
loglog
correl
intranas
absorpt
molecular
weight
watersolubl
compoundsantigen
poor
bioavail
observ
antigen
molecular
weight
greater
kda
paracellular
process
exampl
chitosan
widen
tight
junction
epitheli
cell
transcellular
mechan
antigen
uptak
nasal
lipoid
rout
respons
transport
lipophil
antigen
base
lipophil
transcellular
paracellular
process
antigen
may
also
cross
cell
membran
activ
transport
rout
via
passiv
diffus
depend
ph
environ
pka
drug
carriermedi
mean
transport
open
tight
junction
mucosa
ie
organ
cation
amino
acid
transport
endocyt
process
uptak
antigen
mediat
microfold
cell
variou
factor
affect
antigen
uptak
nasal
caviti
nasal
immun
bioavail
nasal
deliveri
vaccin
depend
two
major
factor
nasal
physiolog
factor
physiochem
properti
nasal
vaccin
formul
differ
physiolog
factor
regul
absorpt
antigen
permeabl
nasal
vaccin
depend
type
cell
number
cell
nasal
caviti
secret
nasal
mucosa
enzym
lactat
dehydrogenas
oxid
conjug
enzym
peptidas
proteas
also
act
barrier
degrad
nasal
vaccin
stimul
nasal
mucosa
play
role
mucos
absorpt
parasympathet
stimul
increas
permeabl
nasal
vaccin
viscou
nasal
mucu
secret
may
retard
uptak
antigen
permeat
antigen
alter
night
chronokinet
due
clearanc
rate
mucos
secret
gener
ph
nasal
caviti
adult
infant
better
antigen
absorpt
develop
nasal
formul
ph
within
mucociliari
clearanc
mcc
take
min
nasal
caviti
increas
mcc
decreas
antigen
uptak
mucociliari
function
may
affect
nasal
mucosa
due
diseas
common
cold
rhiniti
etc
environment
condit
ie
increas
temperatur
increas
mucu
secret
also
affect
mucociliari
clearanc
antigen
concentr
dose
volum
administr
three
interrel
paramet
affect
perform
nasal
antigen
deliveri
ph
nasal
formul
rang
lysozym
found
nasal
secret
respons
destruct
certain
bacteria
acid
ph
lysosom
inactiv
ph
suscept
microbi
infect
nasal
tissu
pharmaceut
dosag
form
anoth
import
factor
consid
develop
nasal
formul
nasal
drop
simpler
conveni
powder
gel
suspens
spray
pharmaceut
excipi
use
formul
buffer
compon
antioxid
preserv
surfact
humact
solubil
gellingviscosifi
agent
also
play
crucial
role
deliveri
antigen
nasal
clearanc
one
major
challeng
develop
nasal
vaccin
nasal
mucosa
mucu
act
sticki
fluid
cilia
act
motiv
prevent
foreign
substanc
pathogen
particl
carri
inhal
air
lung
physiolog
condit
mucu
transport
rate
mmmin
transit
time
human
nasal
caviti
min
depend
length
densiti
beat
frequenc
cilia
well
amount
viscoelast
properti
mucu
absorpt
antigen
influenc
resid
contact
time
antigen
epitheli
tissu
mucosa
mucociliari
clearanc
increas
antigen
absorpt
decreas
ie
invers
proport
nasal
mucociliari
clearanc
also
stimul
inhibit
activ
ingredi
ie
antigen
andor
inact
ingredi
preserv
absorpt
enhanc
andor
excipi
thu
affect
deliveri
antigen
absorpt
site
prolong
resid
time
nasal
caviti
may
also
achiev
use
bioadhes
polym
particul
deliveri
system
increas
viscos
formul
deposit
antigen
anterior
posterior
region
nose
also
affect
antigen
absorpt
nasal
formul
anterior
portion
provid
longer
nasal
resid
time
antigen
low
permeabl
antigen
permeabl
higher
posterior
portion
nose
shorter
nasal
resid
time
exampl
nasal
spray
deposit
anteriorli
clear
slowli
nasal
pharynx
mucociliari
clearanc
nasal
drop
deposit
posteriorli
remov
rapidli
nasal
pharynx
nalt
primari
target
site
nasal
administ
vaccin
consist
lymphoid
follicl
occur
directli
beneath
mucos
follicleassoci
epitheli
fae
cell
nalt
waldey
ring
includ
pharynx
tonsil
induct
site
nasal
immun
nalt
cell
b
cell
cell
dendrit
cell
dc
region
cervic
lymph
node
nasal
immun
vaccin
transport
nalt
fae
contain
special
villou
cell
process
present
villou
cell
lack
brush
border
facilit
bind
deliveri
antigen
also
secret
mucu
enzym
nalt
involv
induct
dc
b
cell
cell
respons
follow
nasal
vaccin
also
produc
local
defens
invad
pathogen
part
solubl
antigen
may
migrat
region
drain
lymph
node
major
histocompat
complex
mhc
th
cell
activ
antigenspecif
helper
cell
th
cell
interact
b
cell
develop
iga
commit
iga
iga
b
cell
rapidli
migrat
nalt
drain
cervic
lymph
node
nasal
passag
differenti
igaproduc
plasma
presenc
cytokin
produc
cell
secret
iga
dimer
dimer
iga
becom
siga
bind
polymer
ig
receptor
transport
iga
effector
site
siga
abl
bind
toxin
bacteria
virus
neutral
activ
thu
prevent
entri
bodi
reach
intern
organ
form
first
barrier
defens
invad
antigen
intranas
administ
vaccin
elicit
neutral
iga
prevent
colon
throat
system
igg
antibodi
facilit
clearanc
system
site
fig
immunecompet
cell
tonsillar
lymphoid
tissu
ciliat
noncili
cell
also
play
role
immun
gener
product
iga
adenoid
tissu
nasal
mucosa
contribut
significantli
immun
protect
inhal
bacteria
virus
mucosa
defend
invad
pathogen
two
type
immun
system
innat
immun
system
adapt
immun
system
key
role
innat
immun
adapt
immun
mucos
surfac
discuss
follow
section
mucos
surfac
nasal
tract
respiratori
tract
adorn
potenti
barrier
known
epitheli
cell
line
epitheli
cell
nasal
mucosa
activ
particip
mucos
defens
epithelia
associ
gland
produc
innat
defens
includ
mucin
antimicrobi
protein
epitheli
cell
detect
dangerousforeign
microbi
compon
pattern
recognit
receptor
tolllik
receptor
tlr
send
cytokin
chemokin
signal
mucou
membraneassoci
apc
dc
macrophag
trigger
nonspecificinn
defens
stimul
adapt
immun
respons
import
characterist
mucosa
product
secret
dimer
iga
resist
degrad
proteaserich
surround
mucos
surfac
human
product
iga
compar
immunoglobulin
isotyp
high
concentr
iga
antibodi
mgml
present
mucos
surfaceassoci
secret
iga
facilit
entrap
microb
foreign
bodi
mucu
avoid
direct
contact
pathogen
mucos
surfac
known
immun
exclus
numer
mucos
rout
immun
avail
altern
current
parenter
immun
name
oral
nasal
pulmonari
vagin
rectal
nasal
rout
attract
sever
reason
practic
site
easi
selfadministr
use
commerci
avail
wide
deliveri
devic
nasal
immun
gener
requir
much
lower
dose
antigen
compar
oral
sometim
parenter
rout
nasal
immun
expos
antigen
low
ph
digest
enzym
like
proteas
nucleas
protect
coat
mucu
limit
access
antigen
mucos
epithelium
administr
vaccin
nasal
rout
may
predominantli
induc
potent
immun
respons
differ
type
deliveri
vehicl
suitabl
nasal
drug
deliveri
system
explor
research
clinic
phase
classifi
two
major
categori
replic
deliveri
system
nonrepl
deliveri
system
replic
deliveri
system
genet
alter
live
viru
act
vector
prolifer
host
tissu
immun
one
preval
effect
present
antigen
like
effect
stimul
immun
respons
follow
oral
nasal
deliveri
differ
viru
vector
rhabdo
viru
polio
viru
influenza
viru
cowpea
mosaic
viru
bacteri
vector
shigella
salmonella
listeria
replic
deliveri
system
abl
induc
ctl
respons
produc
longerlast
immun
introduct
multipl
foreign
gene
replac
nonessenti
region
viral
genom
result
immun
respons
multipl
pathogen
tactic
enabl
recombin
viru
use
vaccin
two
infecti
agent
vaccin
prime
hivenvexpress
influenza
viru
induc
system
cellular
respons
mice
singl
intranas
dose
shigella
vector
base
vaccin
produc
cell
respons
compar
system
immun
replic
antigen
deliveri
system
prefer
due
complex
larg
explor
nonrepl
deliveri
system
mimic
antigen
immun
system
caus
similar
uptak
apc
differ
kind
nonrepl
deliveri
system
includ
liposom
microand
nanoparticul
system
immunestimul
complex
iscom
viruslik
particl
vlp
emuls
bioadhes
deliveri
system
liposom
small
artifici
vesicl
made
bilay
lipid
molecul
phospholipid
cholesterol
encapsul
antigen
liposom
promis
deliveri
system
size
ampiphil
natur
biocompat
vesicl
form
spontan
aqueou
solut
ad
dri
film
lipid
compon
hydrophil
watersolubl
polar
head
portion
lipid
molecul
present
toward
aqueou
phase
hydrophob
waterinsolubl
portion
alli
insid
membran
mani
phospholipid
use
make
liposom
food
product
eg
egg
yolk
soybean
nontox
safe
potenc
liposom
depend
differ
factor
surfac
lipid
layer
electr
charg
composit
method
prepar
liposom
also
act
adjuv
lead
induct
potenti
immun
respons
low
antigen
payload
also
convert
nonimmunogen
substanc
immunogen
form
eg
render
solubl
substanc
particul
natur
liposom
taken
macrophag
cell
antigen
process
andor
present
lymphoid
cell
induct
immun
respons
also
directli
present
antigen
lymphoid
cell
induct
immun
respons
nasal
applic
liposom
contain
bacteri
polysaccharid
antigen
test
balbc
mice
reveal
enhanc
immun
respons
pulmonari
secret
observ
mice
immun
liposom
antigen
comparison
antigen
alon
oral
immun
apart
mani
investig
carri
liposom
use
differ
antigen
describ
tabl
nasal
influenza
vaccin
base
liposom
virosom
formul
influenza
viru
subunit
recent
market
europ
swiss
serum
institut
bern
switzerland
liposom
could
promis
deliveri
system
nasal
vaccin
particul
carrier
attract
consider
interest
antigen
carrier
achiev
deliveri
antigen
specif
site
bodi
nanoparticl
rang
size
iga
antibodi
ctl
respons
nm
microparticl
rang
smaller
particl
size
promot
faster
adsorpt
ad
advantag
includ
stabl
system
protect
hostil
environ
nasal
mucosa
prolong
releas
bioadhes
properti
induct
signific
immun
respons
reduc
dose
depend
method
prepar
microparticl
nanoparticl
prepar
differ
properti
releas
characterist
polym
use
particul
system
biomolecul
protein
peptid
polynucleotid
polysaccharid
synthet
polym
polylactidepolyglycolid
copolym
polyacryl
ntrimethyl
chitosanpoli
acid
nanoand
micros
particul
carrier
prepar
antigen
molecul
deliv
desir
site
action
induc
potent
longlast
immun
respons
mechan
particul
system
alter
induct
immun
respons
sizedepend
penetr
depot
effect
repetit
antigen
display
crosspresent
releas
solubl
mediat
cytokin
regul
immun
respons
mani
studi
carri
microand
nanoparticulatebas
nasal
vaccin
deliveri
system
use
differ
antigen
shown
tabl
henc
polymerbas
micronanoparticul
system
exploit
viabl
nasal
vaccin
deliveri
system
capabl
deliv
multitud
antigen
target
site
induc
desir
immun
respons
iscom
highli
versatil
effect
antigen
present
system
spheric
open
cagelik
structur
typic
nm
diamet
form
spontan
mix
cholesterol
lipid
phosphatidyl
cholin
mixtur
saponin
compris
quillaja
saponin
antigenenvelop
quillaja
saponin
act
strong
inher
adjuv
well
morein
colleagu
show
potenti
induct
immun
respons
upon
immun
iscom
contain
viral
bacteri
membran
glycoprotein
iscom
potent
induc
humor
antibodymedi
immun
respons
also
cellular
cellmedi
immun
respons
present
antigen
unifi
iscom
matrix
allow
process
via
endogen
exogen
pathway
result
stimul
cell
moreov
adjuv
activ
quil
moieti
induc
longlast
immun
respons
antibodi
level
stimul
iscom
found
equival
immun
convent
adjuv
complet
freund
adjuv
alum
studi
reveal
immun
iscom
induc
wide
rang
immun
respons
includ
subclass
igg
cellmedi
immun
respons
delayedtyp
hypersensit
dth
vivo
antigenspecif
prolif
respons
cytokin
product
vitro
addit
properti
iscom
capabl
enter
endogen
antigenprocess
pathway
mhc
class
irestrict
cytotox
cell
ctl
intranas
immun
echinococcu
granulosu
surfac
antigen
iscom
evok
higher
serum
iga
titer
relat
igg
subcutan
rout
mice
sever
studi
differ
antigen
use
iscombas
deliveri
system
shown
tabl
henc
iscombas
deliveri
system
may
suitabl
nasal
vaccin
administr
vlp
promis
option
vaccin
deliveri
nasal
site
easi
access
highli
vascular
self
adjuv
highli
immunostimulatori
rel
larg
surfac
area
low
proteolyt
activ
vlp
inert
nm
selfassembl
empti
capsid
protein
contain
dnarna
show
similar
size
shape
virus
vlp
effici
taken
dc
induc
potent
immun
respons
nasal
immun
induc
system
immun
well
local
distal
mucos
immun
via
common
mucos
immun
system
cmi
even
superior
parenter
administr
elicit
iga
distal
mucos
site
vlp
produc
within
mammalian
cell
insect
cell
yeast
bacteria
even
plant
recombin
dna
techniqu
due
properti
vlp
exploit
deliveri
system
differ
proteinpeptid
antigen
despit
success
usag
potent
immun
vlp
deliveri
system
protein
antigen
still
limit
rel
complic
genet
modif
protein
fusion
subsequ
requir
structur
integr
character
vlp
technolog
use
mani
year
exampl
includ
recombin
hepat
b
surfac
antigen
hbsag
produc
saccharomyc
cerevisia
pichia
pastori
yeast
entir
recombin
core
antigen
hbcag
hepat
b
viru
hbv
promot
immunomodul
immun
respons
coadminist
antigen
includ
hbv
surfac
antigen
hbsag
nasal
administr
concept
also
appli
hiv
dengu
chronic
hepat
c
immunotheraphi
detail
discuss
tabl
vlp
elicit
potent
immun
respons
increas
immunogen
poorli
immunogen
antigen
includ
selfprotein
potenti
micronanoemuls
variou
rout
administr
continu
explor
past
two
decad
due
low
globul
size
lipophil
natur
emuls
wide
chosen
deliveri
system
enhanc
uptak
across
nasal
mucosa
emuls
variou
type
includ
oilinwat
ow
waterinoil
wo
novel
adjuv
made
emuls
incomplet
freund
adjuv
adjuv
montanid
emuls
isotrop
transpar
thermodynam
stabl
low
viscos
colloid
dispers
stabil
interfaci
film
altern
surfact
cosurfact
molecul
eas
administr
scaleup
one
import
advantag
drug
deliveri
system
solid
dispers
liposom
particul
deliveri
system
emuls
formul
contain
differ
inact
ingredi
oil
soybean
oil
sesam
oil
isopropyl
myrist
etc
surfact
tween
chromophor
peg
lecithin
cetrimid
etc
cosurfact
ethanol
propanol
peg
etc
aqueou
phase
mucoadhes
polym
differ
grade
carbopol
eg
sodium
algin
pluron
etc
gener
incorpor
composit
emuls
prolong
releas
antigen
micronanoemuls
provid
good
sprayabl
nasal
vaccin
deliveri
compar
particul
deliveri
system
factor
consid
prepar
formul
includ
natur
concentr
oil
surfact
cosurfact
aqueou
phase
ratio
oil
surfactantcosurfact
temperatur
ph
environ
dilut
particl
size
ph
zeta
potenti
viscos
freezethaw
cycl
critic
paramet
develop
emuls
vaccin
nanoemuls
nasal
vaccin
studi
sever
diseas
like
hepat
b
hiv
influenza
studi
report
nasal
vaccin
immun
produc
strong
igg
iga
antibodi
level
similar
alum
adjuvantbas
vaccin
emulsionbas
deliveri
approach
might
promis
lowcost
nasal
vaccin
immun
popul
develop
underdevelop
countri
bioadhes
deliveri
system
antigen
carrier
system
adher
biolog
tissu
extend
period
nasal
mucosa
bioadhes
protect
antigen
mucos
enzym
increas
retent
time
bioadhesivebas
nasal
vaccin
prefer
overcom
nasal
clearanc
issu
facilit
absorpt
extend
antigen
deliveri
bioadhes
polym
use
increas
nasal
resid
time
slow
mucocilliari
clearanc
allow
absorpt
longer
time
nasal
mucosa
result
subsequ
increas
absorpt
differ
bioadhes
polym
chitosan
carrageenan
carbopol
hydroxypropyl
methylcellulos
hpmc
sodium
algin
sodium
carboxi
methylcellulos
polyvinyl
pyrrolidon
pvp
xanthan
gum
use
formul
bioadhes
occur
polymermucin
chain
van
der
waal
hydrogen
hydrophob
electrostat
forc
nasal
immun
differ
antigen
tetanu
toxoid
influenza
pertussi
diphtheria
follow
encapsul
administr
use
differ
bioadhes
polym
pluron
chitosan
combin
pegcoat
polylact
acid
show
enhanc
immun
respons
via
induct
igg
iga
respons
chitosanbas
influenza
nasal
vaccin
produc
effect
immun
respons
human
clinic
trial
bioadhes
drug
deliveri
system
may
potenti
tool
extend
antigen
deliveri
nasal
immun
intranas
immun
simpl
easi
conveni
safer
rout
administr
deliveri
system
select
depend
upon
antigen
use
propos
indic
patient
type
market
prefer
differ
option
avail
deliv
nasal
vaccin
drop
powder
aerosol
spray
applic
nasal
gel
nasal
drop
conveni
simpl
method
deliveri
nasal
vaccin
nasal
drop
administ
use
nasal
dropper
syring
major
disadvantag
system
lack
dose
precis
difficulti
pediatr
popul
studi
report
nasal
drop
deposit
human
serum
albumin
nostril
effici
nasal
spray
nasal
powder
formul
highli
stabl
compar
liquid
formul
nasal
powder
extend
resid
time
powder
formul
nasal
mucosa
potenti
increas
local
system
immun
respons
howev
product
nasal
dri
powder
quit
complic
requir
particl
size
particl
distribut
perform
characterist
compar
dosag
form
aerosol
rout
deliveri
vaccin
one
prefer
nasal
administr
compar
nasal
dosag
form
also
less
reactogen
subcutan
rout
administr
aerosol
vaccin
via
lung
target
epithelium
critic
host
defens
inhal
pathogen
provid
excit
opportun
develop
newer
effect
tuberculosi
tb
measl
influenza
vaccin
aerosol
vaccin
usual
depend
target
pathogen
site
induct
immun
aerosol
avail
liquid
solut
suspens
emuls
solid
form
addit
vaccin
antigen
carrier
solvent
emulsifiersurfact
corros
inhibitor
propel
select
compat
play
critic
role
achiev
requir
immunogen
infant
aerosol
vaccin
immunogenec
achiev
base
antigen
particl
size
prevent
upper
respiratori
eg
boredetella
pertussi
chlamydia
pneumonia
lower
respiratori
eg
streptococcu
pneumonia
bacillu
anthraci
bacteria
viru
diseas
larger
particl
need
aerosol
vaccin
prevent
upper
respiratori
tract
infect
smaller
particl
lower
respiratori
tract
infect
dri
form
vaccin
optimum
particl
size
tradit
prepar
freez
dri
spray
dri
aerosol
form
vaccin
administ
mani
human
subject
longer
period
found
provid
excel
protect
diseas
influenza
measl
therefor
aerosol
immun
may
promis
method
vaccin
nasal
gel
gener
use
cold
allergi
low
humid
overus
decongest
nasal
vaccin
gel
highviscos
solut
suspens
antigen
molecul
dispers
advantag
nasal
gel
includ
reduct
nasal
clearanc
anterior
leakag
due
highli
viscou
formul
reduct
irrit
use
soothingemolli
excipi
target
deliveri
mucosa
better
absorpt
addit
may
potenti
enhanc
immun
respons
reduc
antigen
andor
adjuv
dose
sustain
antigen
releas
improv
antigen
uptak
enhanc
antigen
stabil
special
applic
techniqu
requir
administr
nasal
gel
vaccin
highli
viscou
formul
poor
spread
abil
wide
varieti
gell
polym
avail
formul
pullulan
deaceyl
gellan
gum
xantham
gum
chitosan
polyethylen
glycol
use
encapsul
vaccineadjuv
formul
gel
particl
viscos
solgel
transit
temperatur
gell
time
gel
strength
textur
critic
paramet
develop
nasal
gel
vaccin
recent
pneumococc
surfac
proteina
nasal
gel
vaccin
clostridium
botulinum
typea
neurotoxin
bohca
tetanu
toxoid
studi
anim
model
enhanc
humor
cellular
immun
nasal
gel
altern
promis
novel
dosag
deliveri
system
achiev
immun
respons
nasal
vaccin
administr
consid
altern
method
found
equival
superior
parenter
mucos
administr
avoid
risk
transmit
diseas
like
hepat
b
hiv
agent
improp
inject
practic
improv
patient
complianc
intranas
vaccin
deliveri
system
induc
mucos
system
immun
respons
avoid
entri
pathogen
mucos
rout
multipl
deliveri
system
explor
development
clinic
phase
open
door
practic
develop
nasal
vaccin
deliveri
system
